Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?

Background: Glioblastoma (GBM) is the most common malignant brain tumor with median survival of 12-15 months. Owing to uncertainty in clinical outcome, additional prognostic marker(s) apart from existing markers are needed. Since overexpression of endothelin B receptor (ETBR) has been demonstrated i...

Full description

Bibliographic Details
Main Authors: Vasaikar, Suhas, Tsipras, Giorgos, Landázuri, Natalia, Costa, Helena, Wilhelmi, Vanessa, Scicluna, Patrick, Cui, Huanhuan L., Mohammad, Abdul Aleem, Davoudi, Belghis, Shang, Mingmei, Ananthaseshan, Sharan, Strååt, Klas, Stragliotto, Giuseppe, Rahbar, Afsar, Wong, Kum Thong, Tegner, Jesper, Yaiw, Koon Chu, Söderberg-Naucler, Cecilia
Format: Article
Published: BioMed Central 2018
Subjects: